tiprankstipranks
Trending News
More News >
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market

Satellos Bioscience (MSCL) Income Statement

Compare
28 Followers

Satellos Bioscience Income Statement

Last quarter (Q3 2025), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Satellos Bioscience's net income was C$-5.82M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92KC$ -48.16K
Operating Expenses
C$ 27.79MC$ 15.46MC$ 8.43MC$ 4.70MC$ 1.43M
Depreciation and Amortization
C$ 20.00KC$ 7.00KC$ 337.00KC$ 165.69KC$ 422.00
EBITDA
C$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60MC$ -1.61M
Operating Income
C$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74MC$ -1.55M
Other Income/Expenses
C$ -291.00KC$ -426.00KC$ -2.89MC$ -8.86MC$ 349.79K
Pretax Income
C$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58M
Net Income
C$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58M
Per Share Metrics
Basic EPS
C$ -2.88C$ -2.16C$ -3.84C$ -7.68C$ -0.58
Diluted EPS
C$ -2.88C$ -2.16C$ -3.84C$ -7.68C$ -0.58
Weighted Average Shares Outstanding
9.56M 7.20M 2.97M 2.01M 2.74M
Weighted Average Shares Outstanding (Diluted)
9.56M 7.20M 2.97M 2.01M 2.74M
Currency in CAD

Satellos Bioscience Earnings and Revenue History